መነሻ › ከኮቪድ በኋላ ያሉ ሁኔታዎች (ረጅም ጊዜ ኮቪድ) › Virginia
በVirginia ለከኮቪድ በኋላ ያሉ ሁኔታዎች (ረጅም ጊዜ ኮቪድ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለከኮቪድ በኋላ ያሉ ሁኔታዎች (ረጅም ጊዜ ኮቪድ) የሚደረጉ 6 ጥናቶች በVirginia ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
Official study text (English)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Velocity Clinical Research - Hampton ( Site 3744), Hampton
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Charlottesville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Velocity Clinical Research, Suffolk, Suffolk
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Charlottesville
- GSK Investigational Site, Newport News
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ65 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- VCU Health System, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT03808922A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- Richard Bennett - Clinical Research Partners, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 4ጤናማ ተሳታዮች ይቀበላሉ
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06585241ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።